jump to navigation

Andro Diagnostics Secures Funding for Further Development of Cancer Screening Test 08/21/2009

Posted by Morse, Barnes-Brown Pendleton in Deal News.
trackback

androMBBP Client Andro Diagnostics, a medical device maker focused on the development and sale of new tests for the detection of prostate cancer, has secured Series B funding which is expected to further research and development of proprietary technologies and to continue human clinical trials.

MBBP advised Andro Diagnostics in this financing. To read the press release and other company news, click here.

Comments»

No comments yet — be the first.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: